Rho GTPases in Gynecologic Cancers: In-Depth Analysis toward the Paradigm Change from Reactive to Predictive, Preventive, and Personalized Medical Approach Benefiting the Patient and Healthcare.
Cancers (Basel)
; 12(5)2020 May 20.
Article
en En
| MEDLINE
| ID: mdl-32443784
Rho GTPases; biomarker-set; breast cancer; cervical cancer; endometrial cancer; function; gynecologic oncology; healing; impairments; in-depth diagnostics; inflammation; metastatic disease; molecular cellular tissue level; ovarian cancers; paradigm change; patient stratification; predictive preventive personalized medicine (PPPM/3PM); prognosis; regulation; signaling pathways; structure; therapy resistance; tumorigenesis
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Cancers (Basel)
Año:
2020
Tipo del documento:
Article
País de afiliación:
Noruega
Pais de publicación:
Suiza